COVID 19 Nucleocapsid (Np) Coronavirus (COVID-19) Recombinant Protein

Recombinant nucleocapsid protein (NP) of SARS-CoV-2 purified from CHO cells

The novel coronavirus (SARS-CoV-2), previously called 2019-nCoV, is a newly identified coronavirus causing the ongoing outbreak of atypical pneumonia in Wuhan China from late 2019.
The genome of SARS-CoV-2 has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleocapsid protein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain (RCB) of SARS-CoV-2 shares only 40% amino acid identity with other SARS-related coronaviruses.

Small volumes of COVID-19 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS434268 is a recombinant protein targeting COVID-19. Also known as Nucleocapsid Protein (NP) of SARS-CoV-2. Host: E Coli.